$IMGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ImmunoGen, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ImmunoGen, Inc.. Get notifications about new insider transactions in ImmunoGen, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 17 2021 | IMGN | ImmunoGen, Inc. | Wallace Richard John | Director | Option Exercise | A | 6.77 | 44,000 | 297,880 | 44,000 | |
Jun 17 2021 | IMGN | ImmunoGen, Inc. | Wallace Richard John | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 87,326 | |
Apr 02 2021 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,666 | 0 | 109,876 | |
Apr 02 2021 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 1,666 | 0 | 93,774 | |
Feb 09 2021 | IMGN | ImmunoGen, Inc. | Enyedy Mark J | Chief Executive Off ... | Option Exercise | A | 7.69 | 925,000 | 7,113,250 | 925,000 | |
Feb 09 2021 | IMGN | ImmunoGen, Inc. | Enyedy Mark J | Chief Executive Off ... | Gift | G | 0.00 | 10,000 | 0 | 429,017 | 439 K to 429 K (-2.28 %) |
Feb 09 2021 | IMGN | ImmunoGen, Inc. | ALTSCHULLER Susan | SVP and CFO | Option Exercise | A | 7.69 | 163,798 | 1,259,607 | 163,798 | |
Feb 09 2021 | IMGN | ImmunoGen, Inc. | Wingrove Theresa | SVP of Regulatory A ... | Option Exercise | A | 7.69 | 121,905 | 937,449 | 121,905 | |
Feb 09 2021 | IMGN | ImmunoGen, Inc. | Coen Stacy Ann | Chief Business Offi ... | Option Exercise | A | 7.69 | 185,016 | 1,422,773 | 185,016 | |
Feb 09 2021 | IMGN | ImmunoGen, Inc. | Lentini Renee | V.P.-Fin., Prin. Ac ... | Option Exercise | A | 7.69 | 80,800 | 621,352 | 80,800 | |
Feb 09 2021 | IMGN | ImmunoGen, Inc. | Berkenblit Anna | SVP & Chief Medical ... | Option Exercise | A | 7.69 | 282,019 | 2,168,726 | 282,019 | |
Jan 11 2021 | IMGN | ImmunoGen, Inc. | Lentini Renee | V.P.-Fin., Prin. Ac ... | Option Exercise | A | 6.98 | 40,400 | 281,992 | 40,400 | |
Jan 11 2021 | IMGN | ImmunoGen, Inc. | Lentini Renee | V.P.-Fin., Prin. Ac ... | Option Exercise | A | 6.98 | 40,400 | 281,992 | 40,400 | |
Jan 05 2021 | IMGN | ImmunoGen, Inc. | Wingrove Theresa | VP of Regulatory Af ... | Grant | A | 4.04 | 2,659 | 10,742 | 75,750 | 73.1 K to 75.8 K (+3.64 %) |
Jan 05 2021 | IMGN | ImmunoGen, Inc. | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Grant | A | 4.04 | 362 | 1,462 | 38,274 | 37.9 K to 38.3 K (+0.95 %) |
Jan 05 2021 | IMGN | ImmunoGen, Inc. | Berkenblit Anna | VP & Chief Medical ... | Grant | A | 4.04 | 2,203 | 8,900 | 103,339 | 101.1 K to 103.3 K (+2.18 %) |
Jan 04 2021 | IMGN | ImmunoGen, Inc. | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Option Exercise | M | 0.00 | 27,240 | 0 | 0 | |
Jan 04 2021 | IMGN | ImmunoGen, Inc. | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Sell | S | 6.38 | 11,052 | 70,512 | 37,912 | 49 K to 37.9 K (-22.57 %) |
Jan 04 2021 | IMGN | ImmunoGen, Inc. | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Buy | M | 0.00 | 27,240 | 0 | 48,964 | 21.7 K to 49 K (+125.39 %) |
Jan 04 2021 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 2,093 | 0 | 92,108 | |
Jan 04 2021 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 2,093 | 0 | 108,210 | |
Oct 01 2020 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 3,750 | 0 | 106,117 | |
Oct 01 2020 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 3,750 | 0 | 90,015 | |
Jul 22 2020 | IMGN | ImmunoGen, Inc. | ALTSCHULLER Susan | SVP and CFO | Option Exercise | A | 4.74 | 300,000 | 1,422,000 | 300,000 | |
Jul 02 2020 | IMGN | ImmunoGen, Inc. | Wingrove Theresa | VP of Regulatory Af ... | Grant | A | 3.91 | 2,593 | 10,139 | 73,091 | 70.5 K to 73.1 K (+3.68 %) |
Jul 02 2020 | IMGN | ImmunoGen, Inc. | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Grant | A | 3.91 | 342 | 1,337 | 21,724 | 21.4 K to 21.7 K (+1.60 %) |
Jul 02 2020 | IMGN | ImmunoGen, Inc. | Enyedy Mark J | Chief Executive Off ... | Grant | A | 3.91 | 5,241 | 20,492 | 439,017 | 433.8 K to 439 K (+1.21 %) |
Jul 02 2020 | IMGN | ImmunoGen, Inc. | Berkenblit Anna | VP & Chief Medical ... | Grant | A | 3.91 | 3,047 | 11,914 | 101,136 | 98.1 K to 101.1 K (+3.11 %) |
Jul 02 2020 | IMGN | ImmunoGen, Inc. | Ryll Thomas | VP, Technical Opera ... | Grant | A | 3.91 | 5,241 | 20,492 | 80,865 | 75.6 K to 80.9 K (+6.93 %) |
Jul 02 2020 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 2,934 | 0 | 86,265 | |
Jul 02 2020 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 2,934 | 0 | 102,367 | |
Jun 18 2020 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 4.56 | 50,000 | 228,000 | 50,000 | |
Jun 18 2020 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 17,000 | 0 | 99,433 | |
Jun 18 2020 | IMGN | ImmunoGen, Inc. | MCCLUSKI STEPHEN C | Director | Option Exercise | A | 4.56 | 50,000 | 228,000 | 50,000 | |
Jun 18 2020 | IMGN | ImmunoGen, Inc. | MCCLUSKI STEPHEN C | Director | Option Exercise | A | 0.00 | 17,000 | 0 | 75,458 | |
Jun 18 2020 | IMGN | ImmunoGen, Inc. | Wallace Richard John | Director | Option Exercise | A | 4.56 | 50,000 | 228,000 | 50,000 | |
Jun 18 2020 | IMGN | ImmunoGen, Inc. | Wallace Richard John | Director | Option Exercise | A | 0.00 | 17,000 | 0 | 72,326 | |
Jun 18 2020 | IMGN | ImmunoGen, Inc. | Peterson Kristine | Director | Option Exercise | A | 4.56 | 50,000 | 228,000 | 50,000 | |
Jun 18 2020 | IMGN | ImmunoGen, Inc. | Peterson Kristine | Director | Option Exercise | A | 0.00 | 17,000 | 0 | 44,954 | |
Jun 18 2020 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 4.56 | 50,000 | 228,000 | 50,000 | |
Jun 18 2020 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 17,000 | 0 | 83,331 | |
Jun 18 2020 | IMGN | ImmunoGen, Inc. | Arbuckle Stuart A | Director | Option Exercise | A | 4.56 | 50,000 | 228,000 | 50,000 | |
Jun 18 2020 | IMGN | ImmunoGen, Inc. | Arbuckle Stuart A | Director | Option Exercise | A | 0.00 | 17,000 | 0 | 33,000 | |
Jun 04 2020 | IMGN | ImmunoGen, Inc. | Coen Stacy Ann | Chief Business Offi ... | Option Exercise | A | 4.92 | 260,000 | 1,279,200 | 260,000 | |
Apr 02 2020 | IMGN | ImmunoGen, Inc. | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Option Exercise | M | 0.00 | 18,160 | 0 | 27,240 | |
Apr 02 2020 | IMGN | ImmunoGen, Inc. | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Sell | S | 3.43 | 5,448 | 18,687 | 21,382 | 26.8 K to 21.4 K (-20.31 %) |
Apr 02 2020 | IMGN | ImmunoGen, Inc. | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Buy | M | 0.00 | 18,160 | 0 | 26,830 | 8.7 K to 26.8 K (+209.46 %) |
Apr 02 2020 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 3,958 | 0 | 66,331 | |
Apr 02 2020 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 3,958 | 0 | 82,433 | |
Apr 02 2020 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 3,958 | 0 | 66,331 | |
Apr 02 2020 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 3,958 | 0 | 82,433 | |
Feb 25 2020 | IMGN | ImmunoGen, Inc. | Ryll Thomas | SVP, Technical Oper ... | Sell | S | 4.99 | 16,790 | 83,782 | 75,624 | 92.4 K to 75.6 K (-18.17 %) |
Feb 25 2020 | IMGN | ImmunoGen, Inc. | Enyedy Mark J | Chief Executive Off ... | Sell | S | 4.99 | 55,222 | 275,558 | 433,776 | 489 K to 433.8 K (-11.29 %) |
Feb 25 2020 | IMGN | ImmunoGen, Inc. | Berkenblit Anna | SVP & Chief Medical ... | Sell | S | 4.99 | 25,803 | 128,757 | 98,089 | 123.9 K to 98.1 K (-20.83 %) |
Feb 25 2020 | IMGN | ImmunoGen, Inc. | Wingrove Theresa | SVP of Regulatory A ... | Sell | S | 4.99 | 16,147 | 80,574 | 70,498 | 86.6 K to 70.5 K (-18.64 %) |
Feb 25 2020 | IMGN | ImmunoGen, Inc. | BARROWS CRAIG | Executive VP, Gener ... | Sell | S | 4.99 | 16,492 | 82,295 | 145,275 | 161.8 K to 145.3 K (-10.19 %) |
Feb 11 2020 | IMGN | ImmunoGen, Inc. | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Option Exercise | A | 4.55 | 76,760 | 349,258 | 76,760 | |
Feb 11 2020 | IMGN | ImmunoGen, Inc. | Wingrove Theresa | SVP of Regulatory A ... | Option Exercise | A | 4.55 | 222,300 | 1,011,465 | 222,300 | |
Feb 11 2020 | IMGN | ImmunoGen, Inc. | Enyedy Mark J | Chief Executive Off ... | Option Exercise | A | 4.55 | 1,050,000 | 4,777,500 | 1,050,000 | |
Feb 11 2020 | IMGN | ImmunoGen, Inc. | Berkenblit Anna | SVP & Chief Medical ... | Option Exercise | A | 4.55 | 296,400 | 1,348,620 | 296,400 | |
Feb 11 2020 | IMGN | ImmunoGen, Inc. | Ryll Thomas | SVP, Technical Oper ... | Option Exercise | A | 4.55 | 222,300 | 1,011,465 | 222,300 | |
Jan 02 2020 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 2,641 | 0 | 78,475 | |
Jan 02 2020 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 2,641 | 0 | 62,373 | |
Nov 21 2019 | IMGN | ImmunoGen, Inc. | Ryll Thomas | SVP, Technical Oper ... | Option Exercise | A | 3.48 | 110,950 | 386,106 | 110,950 | |
Oct 02 2019 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 5,578 | 0 | 75,834 | |
Oct 02 2019 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 5,578 | 0 | 59,732 | |
Jul 22 2019 | IMGN | IMMUNOGEN INC | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Option Exercise | A | 2.31 | 132,900 | 306,999 | 132,900 | |
Jul 02 2019 | IMGN | IMMUNOGEN INC | Berkenblit Anna | VP & Chief Medical ... | Grant | A | 1.84 | 5,230 | 9,623 | 123,892 | 118.7 K to 123.9 K (+4.41 %) |
Jul 02 2019 | IMGN | IMMUNOGEN INC | Enyedy Mark J | Chief Executive Off ... | Grant | A | 1.84 | 5,230 | 9,623 | 488,998 | 483.8 K to 489 K (+1.08 %) |
Jul 02 2019 | IMGN | IMMUNOGEN INC | Ryll Thomas | VP, Technical Opera ... | Grant | A | 1.84 | 5,230 | 9,623 | 92,414 | 87.2 K to 92.4 K (+6.00 %) |
Jul 02 2019 | IMGN | IMMUNOGEN INC | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Grant | A | 1.84 | 3,536 | 6,506 | 8,008 | 4.5 K to 8 K (+79.07 %) |
Jul 02 2019 | IMGN | IMMUNOGEN INC | McKee Blaine H. | EVP & Chief Busines ... | Grant | A | 1.84 | 5,230 | 9,623 | 5,230 | 0 to 5.2 K |
Jul 02 2019 | IMGN | IMMUNOGEN INC | BARROWS CRAIG | Executive VP, Gener ... | Grant | A | 1.84 | 5,230 | 9,623 | 161,767 | 156.5 K to 161.8 K (+3.34 %) |
Jul 01 2019 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 6,221 | 0 | 54,154 | |
Jul 01 2019 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 6,221 | 0 | 70,256 | |
Jun 24 2019 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 2.10 | 18,000 | 37,800 | 18,000 | |
Jun 24 2019 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 64,035 | |
Jun 24 2019 | IMGN | IMMUNOGEN INC | MCCLUSKI STEPHEN C | Director | Option Exercise | A | 2.10 | 18,000 | 37,800 | 18,000 | |
Jun 24 2019 | IMGN | IMMUNOGEN INC | MCCLUSKI STEPHEN C | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 58,458 | |
Jun 24 2019 | IMGN | IMMUNOGEN INC | Wallace Richard John | Director | Option Exercise | A | 2.10 | 18,000 | 37,800 | 18,000 | |
Jun 24 2019 | IMGN | IMMUNOGEN INC | Wallace Richard John | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 55,326 | |
Jun 24 2019 | IMGN | IMMUNOGEN INC | Peterson Kristine | Director | Option Exercise | A | 2.10 | 18,000 | 37,800 | 18,000 | |
Jun 24 2019 | IMGN | IMMUNOGEN INC | Peterson Kristine | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 27,954 | |
Jun 24 2019 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 2.10 | 18,000 | 37,800 | 18,000 | |
Jun 24 2019 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 47,933 | |
Jun 24 2019 | IMGN | IMMUNOGEN INC | Arbuckle Stuart A | Director | Option Exercise | A | 2.10 | 18,000 | 37,800 | 18,000 | |
Jun 24 2019 | IMGN | IMMUNOGEN INC | Arbuckle Stuart A | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 16,000 | |
Apr 08 2019 | IMGN | IMMUNOGEN INC | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Option Exercise | A | 0.00 | 45,400 | 0 | 45,400 | |
Apr 01 2019 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 4,981 | 0 | 60,035 | |
Apr 01 2019 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 4,981 | 0 | 42,933 | |
Feb 25 2019 | IMGN | IMMUNOGEN INC | Enyedy Mark J | Chief Executive Off ... | Sell | S | 5.60 | 51,070 | 285,992 | 483,768 | 534.8 K to 483.8 K (-9.55 %) |
Feb 25 2019 | IMGN | IMMUNOGEN INC | Ryll Thomas | VP, Technical Opera ... | Sell | S | 5.60 | 11,495 | 64,372 | 87,184 | 98.7 K to 87.2 K (-11.65 %) |
Feb 25 2019 | IMGN | IMMUNOGEN INC | Wingrove Theresa | VP of Regulatory Af ... | Sell | S | 5.60 | 11,032 | 61,779 | 81,883 | 92.9 K to 81.9 K (-11.87 %) |
Feb 25 2019 | IMGN | IMMUNOGEN INC | Berkenblit Anna | VP & Chief Medical ... | Sell | S | 5.60 | 16,562 | 92,747 | 118,662 | 135.2 K to 118.7 K (-12.25 %) |
Feb 25 2019 | IMGN | IMMUNOGEN INC | BARROWS CRAIG | Executive VP, Gener ... | Sell | S | 5.60 | 14,870 | 83,272 | 156,537 | 171.4 K to 156.5 K (-8.68 %) |
Feb 25 2019 | IMGN | IMMUNOGEN INC | Gregory Richard J. | Executive VP & CSO | Sell | S | 5.60 | 36,643 | 205,201 | 199,413 | 236.1 K to 199.4 K (-15.52 %) |
Feb 06 2019 | IMGN | IMMUNOGEN INC | Wingrove Theresa | VP of Regulatory Af ... | Option Exercise | A | 4.83 | 58,900 | 284,487 | 58,900 | |
Feb 04 2019 | IMGN | IMMUNOGEN INC | Ryll Thomas | VP, Technical Opera ... | Option Exercise | A | 5.25 | 221,900 | 1,164,975 | 221,900 | |
Feb 04 2019 | IMGN | IMMUNOGEN INC | Gregory Richard J. | Executive VP & CSO | Option Exercise | A | 5.25 | 289,150 | 1,518,038 | 289,150 | |
Feb 04 2019 | IMGN | IMMUNOGEN INC | BARROWS CRAIG | Vice-President,Gene ... | Option Exercise | A | 5.25 | 231,750 | 1,216,688 | 231,750 | |
Feb 04 2019 | IMGN | IMMUNOGEN INC | Berkenblit Anna | VP & Chief Medical ... | Option Exercise | A | 5.25 | 92,500 | 485,625 | 92,500 | |
Feb 04 2019 | IMGN | IMMUNOGEN INC | Berkenblit Anna | VP & Chief Medical ... | Option Exercise | A | 5.25 | 256,050 | 1,344,263 | 256,050 | |
Feb 04 2019 | IMGN | IMMUNOGEN INC | Enyedy Mark J | Chief Executive Off ... | Option Exercise | A | 5.25 | 785,000 | 4,121,250 | 785,000 | |
Feb 04 2019 | IMGN | IMMUNOGEN INC | Wingrove Theresa | VP of Regulatory Af ... | Option Exercise | A | 5.25 | 126,100 | 662,025 | 126,100 | |
Feb 04 2019 | IMGN | IMMUNOGEN INC | McKee Blaine H. | EVP & Chief Busines ... | Option Exercise | A | 5.25 | 173,140 | 908,985 | 173,140 | |
Feb 04 2019 | IMGN | IMMUNOGEN INC | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Option Exercise | A | 5.25 | 58,100 | 305,025 | 58,100 | |
Jan 08 2019 | IMGN | IMMUNOGEN INC | Gregory Richard J. | Executive VP & CSO | Sell | S | 5.27 | 3,038 | 16,014 | 236,056 | 239.1 K to 236.1 K (-1.27 %) |
Jan 04 2019 | IMGN | IMMUNOGEN INC | BARROWS CRAIG | Executive VP, Gener ... | Grant | A | 4.08 | 2,455 | 10,016 | 171,407 | 169 K to 171.4 K (+1.45 %) |
Jan 04 2019 | IMGN | IMMUNOGEN INC | Wingrove Theresa | VP of Regulatory Af ... | Grant | A | 4.08 | 2,244 | 9,156 | 92,915 | 90.7 K to 92.9 K (+2.47 %) |
Jan 04 2019 | IMGN | IMMUNOGEN INC | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Grant | A | 4.08 | 1,472 | 6,006 | 3,472 | 2 K to 3.5 K (+73.60 %) |
Jan 04 2019 | IMGN | IMMUNOGEN INC | Ryll Thomas | VP, Technical Opera ... | Grant | A | 4.08 | 2,455 | 10,016 | 98,679 | 96.2 K to 98.7 K (+2.55 %) |
Jan 04 2019 | IMGN | IMMUNOGEN INC | Enyedy Mark J | Chief Executive Off ... | Grant | A | 4.08 | 2,455 | 10,016 | 534,838 | 532.4 K to 534.8 K (+0.46 %) |
Jan 04 2019 | IMGN | IMMUNOGEN INC | Berkenblit Anna | VP & Chief Medical ... | Grant | A | 4.08 | 2,455 | 10,016 | 135,224 | 132.8 K to 135.2 K (+1.85 %) |
Jan 02 2019 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 2,812 | 0 | 55,054 | |
Jan 02 2019 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 2,812 | 0 | 38,952 | |
Nov 07 2018 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Buy | P | 5.76 | 30,000 | 172,800 | 53,800 | 23.8 K to 53.8 K (+126.05 %) |
Oct 17 2018 | IMGN | IMMUNOGEN INC | Berkenblit Anna | VP & Chief Medical ... | Sell | S | 8.00 | 5,851 | 46,808 | 132,769 | 138.6 K to 132.8 K (-4.22 %) |
Oct 01 2018 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 1,425 | 0 | 36,140 | |
Oct 01 2018 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,425 | 0 | 52,242 | |
Sep 11 2018 | IMGN | IMMUNOGEN INC | Berkenblit Anna | VP & Chief Medical ... | Sell | S | 9.46 | 5,851 | 55,350 | 138,620 | 144.5 K to 138.6 K (-4.05 %) |
Jul 02 2018 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 1,387 | 0 | 34,715 | |
Jul 02 2018 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,227 | 0 | 50,817 | |
Jun 22 2018 | IMGN | IMMUNOGEN INC | Arbuckle Stuart A | Director | Option Exercise | A | 11.21 | 15,800 | 177,118 | 15,800 | |
Jun 22 2018 | IMGN | IMMUNOGEN INC | Arbuckle Stuart A | Director | Option Exercise | A | 0.00 | 1,500 | 0 | 12,000 | |
Jun 22 2018 | IMGN | IMMUNOGEN INC | Arbuckle Stuart A | Director | Option Exercise | A | 11.21 | 18,000 | 201,780 | 18,000 | |
Jun 22 2018 | IMGN | IMMUNOGEN INC | Arbuckle Stuart A | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 10,500 | |
Jun 22 2018 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 11.21 | 18,000 | 201,780 | 18,000 | |
Jun 22 2018 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 49,590 | |
Jun 22 2018 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 11.21 | 18,000 | 201,780 | 18,000 | |
Jun 22 2018 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 33,328 | |
Jun 22 2018 | IMGN | IMMUNOGEN INC | Wallace Richard John | Director | Option Exercise | A | 11.21 | 18,000 | 201,780 | 18,000 | |
Jun 22 2018 | IMGN | IMMUNOGEN INC | Wallace Richard John | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 51,326 | |
Jun 22 2018 | IMGN | IMMUNOGEN INC | Peterson Kristine | Director | Option Exercise | A | 11.21 | 18,000 | 201,780 | 18,000 | |
Jun 22 2018 | IMGN | IMMUNOGEN INC | Peterson Kristine | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 23,954 | |
Jun 22 2018 | IMGN | IMMUNOGEN INC | MCCLUSKI STEPHEN C | Director | Option Exercise | A | 11.21 | 18,000 | 201,780 | 18,000 | |
Jun 22 2018 | IMGN | IMMUNOGEN INC | MCCLUSKI STEPHEN C | Director | Option Exercise | A | 0.00 | 4,000 | 0 | 54,458 | |
Apr 02 2018 | IMGN | IMMUNOGEN INC | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,118 | 0 | 45,590 | |
Apr 02 2018 | IMGN | IMMUNOGEN INC | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 1,283 | 0 | 29,328 | |
Mar 16 2018 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Option Exercise | M | 4.29 | 25,000 | 107,250 | 113,518 | |
Mar 16 2018 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Sell | S | 12.02 | 25,000 | 300,405 | 184,987 | 210 K to 185 K (-11.91 %) |
Mar 16 2018 | IMGN | IMMUNOGEN INC | JUNIUS DANIEL M | Director | Buy | M | 4.29 | 25,000 | 107,250 | 209,987 | 185 K to 210 K (+13.51 %) |
Mar 16 2018 | IMGN | IMMUNOGEN INC | Johnston David Brannon | Chief Financial Off ... | Option Exercise | M | 3.05 | 10,000 | 30,500 | 100,000 | |
Mar 16 2018 | IMGN | IMMUNOGEN INC | Johnston David Brannon | Chief Financial Off ... | Sell | S | 11.53 | 10,000 | 115,300 | 180,690 | 190.7 K to 180.7 K (-5.24 %) |
Mar 16 2018 | IMGN | IMMUNOGEN INC | Johnston David Brannon | Chief Financial Off ... | Buy | M | 3.05 | 10,000 | 30,500 | 190,690 | 180.7 K to 190.7 K (+5.53 %) |
Feb 23 2018 | IMGN | IMMUNOGEN INC | Enyedy Mark J | Chief Executive Off ... | Sell | S | 10.87 | 67,717 | 736,084 | 532,383 | 600.1 K to 532.4 K (-11.28 %) |
Feb 23 2018 | IMGN | IMMUNOGEN INC | Ryll Thomas | VP, Technical Opera ... | Sell | S | 10.88 | 11,876 | 129,211 | 96,224 | 108.1 K to 96.2 K (-10.99 %) |
Feb 23 2018 | IMGN | IMMUNOGEN INC | Wingrove Theresa | VP of Regulatory Af ... | Sell | S | 10.88 | 11,379 | 123,804 | 90,671 | 102.1 K to 90.7 K (-11.15 %) |
Feb 23 2018 | IMGN | IMMUNOGEN INC | Johnston David Brannon | Chief Financial Off ... | Sell | S | 10.87 | 21,060 | 228,922 | 180,690 | 201.8 K to 180.7 K (-10.44 %) |
Feb 23 2018 | IMGN | IMMUNOGEN INC | Berkenblit Anna | VP & Chief Medical ... | Sell | S | 10.88 | 17,329 | 188,540 | 144,471 | 161.8 K to 144.5 K (-10.71 %) |
Feb 23 2018 | IMGN | IMMUNOGEN INC | BARROWS CRAIG | Executive VP, Gener ... | Sell | S | 10.88 | 15,498 | 168,618 | 168,952 | 184.5 K to 169 K (-8.40 %) |